Huhn Stephen L.
SEC insider (Form 3/4/5 filer). CIK 0001863904. CMO & Sr VP, Clinical Dev. at Contineum Therapeutics, Inc. (CTNM). 1 reported Form 4/5 transaction since Sep 2024; latest on Jan 31, 2025. Located in SAN DIEGO, CA.
Companies Huhn Stephen L. has filed insider reports for
- Contineum Therapeutics, Inc. (CTNM): Officer, CMO & Sr VP, Clinical Dev.
Huhn Stephen L.
CIK: 0001863904
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTNM
Contineum Therapeutics, Inc.
Officer